Sean leads our Legal Services team. He advises a wide range of clients on the protection, defence, enforcement and commercialisation of intellectual property (IP) and data rights across a range of industry sectors. Sean has particular experience in the biotechnology, pharmaceutical, engineering and nanotech sectors. His practice also covers technology transfer, medicine regulatory exclusivity, human tissue and advanced therapy medicinal products regulations, medical device CE marking, clinical trials and GDPR. By way of example, Sean supports his clients by:
Sean is a highly regarded IP lawyer. He is ranked as a ‘Notable Practitioner’ in Chambers & Partners (2015) which reported clients saying that “I was very impressed by the high standard of the work undertaken, applying experience from other transactions and using a very clear, approachable communication style.” and “They’re always on-the-ball and know their stuff.” In Chambers & Partners (2014), clients observed that Sean “very quickly understands the strategy and detail in a very complex contract, and uses his extremely good communication skills to make constructive comments for discussion.” Other sources noted that he “is extremely commercially astute, dedicated to his clients and a pleasure to work with. He explains complex issues in a coherent and concise way, and is able to offer high-level advice in a cost-effective manner.”
He is also recognised as having “expertise in IP protection, commercialisation and rights enforcement, with a strong presence in the life sciences, engineering and nanotechnology sectors” in The Legal 500 (2014) and being “‘very thorough’; he led on the hard-IP aspects of two AIM IPOs” – The Legal 500 (2015).
Sean and his team receive praise in The Legal 500 (2016) as researchers comment: “Boutique firm Mewburn Ellis LLP excels in the life sciences, nano-material, chemical engineering and university technology transfer arenas”. Sean and the Legal Services team have once again been recognised in the 2017 edition of The Legal 500 as “particularly strong in the life sciences space, advising universities as well as spin-out and start-up companies on managing portfolios that cover major blockbuster drugs.”
Sean’s clients appreciate his talent for “explaining complicated concepts with clarity and concision”. – Chambers & Partners 2016. In Chambers & Partners 2018 Sean is recognised for his work advising on all facets of prosecution, licensing and litigation. One client says: “He explains complex ideas in a way that’s easy to understand, he identifies areas of risk and he is a real pleasure to work with.”
Sean has been recognised as an “IP Star” in the Managing Intellectual Property: IP Stars directory from 2016 – 2019. He is recommended for IP-related legal transactions.
Sean regularly provides tailored IP seminars to our clients. He also contributes to a number of professionally run IP training courses and regularly comments on, or publishes articles relating to, topical IP matters.
Sean has a BSc in microbiology from Imperial College, London and a PhD in microbiology from the University of Cambridge. He obtained a Postgraduate Diploma in Law from the College of Law, London, after which he trained as a solicitor at a ‘magic circle’ London law firm, qualifying in 2003. Following qualification Sean established and managed the technology transfer office at the London School of Hygiene & Tropical Medicine. In 2007 he joined the transactional IP team in the Bristol office of a major international law firm becoming their lead ‘hard’ IP lawyer. Sean joined Mewburn Ellis to head our Legal Services team in 2011.